Temporal IgG Subtype Changes in Recurrent Idiopathic Membranous Nephropathy

American Journal of Transplantation

Volumn 16, Issue 10, 2016, Pages 2964-2972

  Kattah, A G ^a   Alexander, M P ^a   Angioi, A ^b   De Vriese, A S ^c   Sethi, S ^a   Cosio, F G ^a   Lorenz, E C ^a   Cornell, L D ^a   Fervenza, F C ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c Department of Internal Medicine   (Belgium)

Author keywords

clinical research practice; glomerular biology and disease; immune regulation; kidney transplantation nephrology; pathology histopathology; recurrent disease

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; PHOSPHOLIPASE A2 RECEPTOR; RITUXIMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 84988672504     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13806     Document Type: Article

References (21)

1. Doi T, Mayumi M, Kanatsu K, Suehiro F, Hamashima Y. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol 1984; 58: 57–62.
2. Kuroki A, Shibata T, Honda H, Totsuka D, Kobayashi K, Sugisaki T. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 2002; 41: 936–942.
3. Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 2004; 19: 574–579.
4. Kearney N, Podolak J, Matsumura L, Houghton D, Troxell M. Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts. Transplant Proc 2011; 43: 3743–3746.
5. Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11–21.
6. Hofstra JM, Beck LH, Jr., Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6: 1286–1291.
7. Hoxha E, Harendza S, Zahner G, et al. An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011; 26: 2526–2532.
8. Debiec H, Martin L, Jouanneau C, et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy. Am J Transplant 2011; 11: 2144–2152.
9. Qin W, Beck LH, Jr., Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1137–1143.
10. Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS ONE 2013; 8: e62151.
11. Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014; 371: 2277–2287.
12. Huang CC, Lehman A, Albawardi A, et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol 2013; 26: 799–805.
13. Seitz-Polski B, Dolla G, Payre C, et al. Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy. J Am Soc Nephrol 2015; 27: 1517–1533.
14. Rodriguez EF, Cosio FG, Nasr SH, et al. The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant 2012; 12: 1029–1038.
15. Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 2013; 26: 709–715.
16. Kattah A, Ayalon R, Beck LH, Jr., et al. Anti-phospholipase A(2) receptor antibodies in recurrent membranous nephropathy. Am J Transplant 2015; 15: 1349–1359.
17. Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology 2002; 105: 9–19.
18. Beck LH, Jr., Salant DJ. Membranous nephropathy: From models to man. J Clin Invest 2014; 124: 2307–2314.
19. Ma H, Sandor DG, Beck LH, Jr. The role of complement in membranous nephropathy. Semin Nephrol 2013; 33: 531–542.
20. van de Logt AE, Hofstra JM, Wetzels JF. Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: Seroconversion after prolonged follow-up. Kidney Int 2015; 87: 1263–1264.
21. Ramachandran R, Kumar V, Nada R, Jha V. Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy. Kidney Int 2015; 88: 1198–1199.